TY - JOUR
T1 - Economic Analysis of the Tailored Activity Program
T2 - A Nonpharmacological Approach to Improve Quality of Life in People Living With Dementia and their Caregivers
AU - Pizzi, Laura T.
AU - Prioli, Katherine M.
AU - Jutkowitz, Eric
AU - Piersol, Catherine V.
AU - Lyketsos, Constantine G.
AU - Abersone, Ilze
AU - Marx, Katherine A.
AU - Gitlin, Laura N
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a grand from National Institute of Aging [R01 AG041781, 1R21 AG059623, 2012–2018] and by the Johns Hopkins Alzheimer’s disease research Center [P30 AG066507]. The funders played no role in the design of the study or collection, analysis, interpretation of data or of writing the manuscript.
Publisher Copyright:
© The Author(s) 2023.
PY - 2023/7
Y1 - 2023/7
N2 - We investigated costs of delivering the Tailored Activity Program (TAP) and cost savings from two perspectives (health sector and societal) for people living with dementia (PLWD) and their caregivers (dyads) compared to attention control (AC) using data from a randomized controlled trial. The evaluation assessed intervention delivery costs and caregiver reported health care utilization. The total intervention cost of TAP was $1707/dyad versus $864/dyad for AC, and total costs over 6 months for TAP dyads as compared to AC were $1299 (CI: -$10,496, $7898) less from the healthcare perspective, and $761 (CI: -$10,133, $8611) less from the societal perspective. TAP cost savings are driven by lower use of healthcare services among participating dyads, but further analyses with larger samples is warranted to confirm its financial impact.
AB - We investigated costs of delivering the Tailored Activity Program (TAP) and cost savings from two perspectives (health sector and societal) for people living with dementia (PLWD) and their caregivers (dyads) compared to attention control (AC) using data from a randomized controlled trial. The evaluation assessed intervention delivery costs and caregiver reported health care utilization. The total intervention cost of TAP was $1707/dyad versus $864/dyad for AC, and total costs over 6 months for TAP dyads as compared to AC were $1299 (CI: -$10,496, $7898) less from the healthcare perspective, and $761 (CI: -$10,133, $8611) less from the societal perspective. TAP cost savings are driven by lower use of healthcare services among participating dyads, but further analyses with larger samples is warranted to confirm its financial impact.
KW - caregivers
KW - costs
KW - dementia
KW - economic evaluation
KW - healthcare utilization
UR - http://www.scopus.com/inward/record.url?scp=85149366986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149366986&partnerID=8YFLogxK
U2 - 10.1177/07334648231158091
DO - 10.1177/07334648231158091
M3 - Article
C2 - 36814387
AN - SCOPUS:85149366986
SN - 0733-4648
VL - 42
SP - 1433
EP - 1444
JO - Journal of Applied Gerontology
JF - Journal of Applied Gerontology
IS - 7
ER -